Educational use only. Check doses against the product monograph and local protocols.

rescue vasoactive agents

in review 2 min read Updated 2026-10-29
rescue vasoactive agents

Used after norepinephrine ± vasopressin ± epinephrine, or for a specific niche. Methylene blue: raises BP in refractory vasoplegia, survival benefit unproven (SSC: insufficient evidence). Angiotensin II and levosimendan have no Health Canada listing. Isoproterenol: chronotrope for bradycardia, torsades and the denervated heart. Midodrine: oral α1 agonist for weaning low-dose pressors (unproven) and HRS with octreotide.

agents

agentmechanismdoserolecautions
methylene blueinhibits NO synthase and guanylate cyclase → restores vascular tone1–2 mg/kg IV over 5–30 min (trial regimens varied)refractory septic shock, post-bypass vasoplegia; first-line for methaemoglobinaemiaserotonin toxicity with SSRIs/SNRIs (Health Canada warning); G6PD deficiency (haemolysis, less effective); falsely low SpO₂, blue-green urine
angiotensin IIAT1 agonist (RAAS pathway)— (no Health Canada DPD listing, checked 2026-10-29)catecholamine-refractory vasodilatory shock (ATHOS-3 (2017): better MAP response, no proven mortality gain)thrombosis → VTE prophylaxis
levosimendancalcium sensitiser + K-ATP opener0.1 mcg/kg/min (0.05–0.2), ESC (no Health Canada DPD listing)low-output HF on β-blockershypotension; long-acting metabolite. Not for septic shock (SSC: suggest against)
isoproterenolβ1 + β2 agonist20–60 mcg IV bolus then 10–20 mcg, or 1–20 mcg/min titrated to HRbradycardia when atropine fails (bridge to pacing), heart transplantvasodilation → hypotension; ischaemia, tachyarrhythmia
midodrineoral α1 agonist (prodrug)HRS: 7.5–15 mg PO q8h with octreotideHRS-AKI only if terlipressin is contraindicated and ICU norepinephrine isn’t possible (ADQI-ICA); weaning low-dose pressorsbradyarrhythmias. SSC: insufficient evidence in septic shock

key points

  • order in septic shock: norepinephrine → vasopressin → epinephrine; methylene blue as rescue. It may raise BP and probably shortens vasopressor duration by ~1 day (moderate certainty); the mortality effect is very uncertain, and 69% of the SSC panel “never or almost never” use it. Where vasopressin is unavailable it may be the only second-line option (SSC) → septic shock
  • methylene blue + serotonergic drug (SSRI, SNRI, linezolid, fentanyl) → serotonin syndrome. Check the medication list first
  • isoproterenol is a chronotrope and vasodilator, not a pressor; don’t use it for hypotension without bradycardia
  • terlipressin (V1 agonist) for HRS-AKI → hepatorenal syndrome; hydroxocobalamin (cyanide, refractory vasoplegia) → toxicology

Standard pressors and inotropes: vasoactive drugs.

Prepared 2026-10-29. Not yet verified — check every number against the sources.

Key references

+5 more sources

Suggest a correction rescue vasoactive agents